Xiaojuan Mi
About
Xiaojuan Mi is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Xiaojuan Mi has authored 54 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cardiology and Cardiovascular Medicine, 8 papers in Economics and Econometrics and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaojuan Mi's work include Heart Failure Treatment and Management (18 papers), Cardiac pacing and defibrillation studies (12 papers) and Cardiac Arrhythmias and Treatments (9 papers). Xiaojuan Mi is often cited by papers focused on Heart Failure Treatment and Management (18 papers), Cardiac pacing and defibrillation studies (12 papers) and Cardiac Arrhythmias and Treatments (9 papers). Xiaojuan Mi collaborates with scholars based in United States, United Kingdom and China. Xiaojuan Mi's co-authors include Lesley H. Curtis, Adrian F. Hernandez, Gregg C. Fonarow, Adam D. DeVore, Puza P. Sharma, Carol I. Duffy, Laine Thomas, Fredonia B. Williams, John A. Spertus and Nancy M. Albert and has published in prestigious journals such as JAMA, Circulation and Annals of Internal Medicine.
In The Last Decade
Xiaojuan Mi
52 papers receiving 2.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Xiaojuan Mi United States | 25 | 1.5k | 501 | 361 | 359 | 205 | 54 | 2.4k | ||
| Sameer Bansilal United States | 25 | 1.6k 1.1× | 732 1.5× | 436 1.2× | 659 1.8× | 138 0.7× | 68 | 3.2k | ||
| Ruoxiang Jiang United States | 28 | 2.0k 1.3× | 487 1.0× | 177 0.5× | 339 0.9× | 129 0.6× | 67 | 3.1k | ||
| Amit Kiran United Kingdom | 16 | 1.8k 1.2× | 282 0.6× | 464 1.3× | 619 1.7× | 170 0.8× | 26 | 3.0k | ||
| Charles Porter United States | 18 | 2.2k 1.4× | 256 0.5× | 209 0.6× | 564 1.6× | 136 0.7× | 38 | 3.1k | ||
| Shweta R. Motiwala United States | 23 | 1.7k 1.1× | 276 0.6× | 291 0.8× | 385 1.1× | 58 0.3× | 42 | 2.4k | ||
| Mary Tan Canada | 25 | 1.7k 1.1× | 223 0.4× | 282 0.8× | 676 1.9× | 235 1.1× | 93 | 2.5k | ||
| A. Mosterd Netherlands | 7 | 2.3k 1.5× | 250 0.5× | 170 0.5× | 313 0.9× | 87 0.4× | 9 | 2.8k | ||
| Yumin Zhao United States | 20 | 763 0.5× | 108 0.2× | 390 1.1× | 171 0.5× | 144 0.7× | 39 | 1.9k | ||
| Bruce M. Psaty United States | 14 | 921 0.6× | 208 0.4× | 328 0.9× | 195 0.5× | 152 0.7× | 19 | 1.7k | ||
| Piotr Jankowski Poland | 26 | 1.4k 0.9× | 198 0.4× | 244 0.7× | 589 1.6× | 176 0.9× | 211 | 2.4k |
Countries citing papers authored by Xiaojuan Mi
Since
Specialization
Citations
This map shows the geographic impact of Xiaojuan Mi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojuan Mi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojuan Mi more than expected).
Fields of papers citing papers by Xiaojuan Mi
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Xiaojuan Mi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojuan Mi. The network helps show where Xiaojuan Mi may publish in the future.
Co-authorship network of co-authors of Xiaojuan Mi
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojuan Mi. A scholar is included among the top collaborators of Xiaojuan Mi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojuan Mi. Xiaojuan Mi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Li, Haixiang, Yu Han, Yanhao Zhang, et al.. (2024). Optimization of nitrogen removal and microbial mechanism of a hydrogen-based membrane biofilm reactor. Environmental Technology. 45(27). 5982–5998.
2.
Greene, Stephen J., Javed Butler, Nancy M. Albert, et al.. (2018). Medical Therapy for Heart Failure With Reduced Ejection Fraction. Journal of the American College of Cardiology. 72(4). 351–366.
3.
Khariton, Yevgeniy, Michael E. Nassif, Laine Thomas, et al.. (2018). Health Status Disparities by Sex, Race/Ethnicity, and Socioeconomic Status in Outpatients With Heart Failure. JACC Heart Failure. 6(6). 465–473.
4.
Khariton, Yevgeniy, Michael E. Nassif, Laine Thomas, et al.. (2017). Abstract 19403: Gender and Socioeconomic Disparities With Health Status in Outpatients With Heart Failure: Insights From the CHAMP-HF Registry. Circulation.
5.
Maciejewski, Matthew L., Xiaojuan Mi, Lesley H. Curtis, et al.. (2016). Frequency of Disparities in Laboratory Testing After Statin Initiation in Subjects ≥65 Years. The American Journal of Cardiology. 118(3). 376–382.
6.
Jones, W. Schuyler, Xiaojuan Mi, Laura G. Qualls, et al.. (2016). Significant variation in P2Y12 inhibitor use after peripheral vascular intervention in Medicare beneficiaries. American Heart Journal. 179. 10–18.
7.
Jones, W. Schuyler, Xiaojuan Mi, Laura G. Qualls, et al.. (2015). Trends in Settings for Peripheral Vascular Intervention and the Effect of Changes in the Outpatient Prospective Payment System. Journal of the American College of Cardiology. 65(9). 920–927.
8.
DeVore, Adam D., Xiaojuan Mi, Robert J. Mentz, et al.. (2015). Discharge heart rate and β-blocker dose in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF registry. American Heart Journal. 173. 172–178.
9.
Durheim, Michael T., et al.. (2015). Early and Long-term Outcomes of Older Adults after Acute Care Encounters for Chronic Obstructive Pulmonary Disease Exacerbation. Annals of the American Thoracic Society. 12(12). 1805–1812.
10.
Jones, W. Schuyler, Xiaojuan Mi, Sreekanth Vemulapalli, et al.. (2014). TCT-536 Trends In Revascularization For Patients With Lower Extremity Peripheral Artery Disease: The Impact of Medicare Coverage Determination. Journal of the American College of Cardiology. 64(11). B157–B157.
11.
Masoudi, Frederick A., Xiaojuan Mi, Lesley H. Curtis, et al.. (2014). Comparative Effectiveness of Cardiac Resynchronization Therapy With an Implantable Cardioverter-Defibrillator Versus Defibrillator Therapy Alone. Annals of Internal Medicine. 160(9). 603–611.
12.
Wong, Yee Weng, Gregg C. Fonarow, Xiaojuan Mi, et al.. (2013). TIME TO INTRAVENOUS THERAPY AND CLINICAL OUTCOMES IN OLDER PATIENTS PRESENTING WITH ACUTE DECOMPENSATED HEART FAILURE: AN ANALYSIS OF THE ADHERE REGISTRY EMERGENCY MODULE. Journal of the American College of Cardiology. 61(10). E622–E622.
13.
Wong, Yee Weng, Gregg C. Fonarow, Xiaojuan Mi, et al.. (2013). Early intravenous heart failure therapy and outcomes among older patients hospitalized for acute decompensated heart failure: Findings from the Acute Decompensated Heart Failure Registry Emergency Module (ADHERE-EM). American Heart Journal. 166(2). 349–356.
14.
Eapen, Zubin J., Xiaojuan Mi, Laura G. Qualls, et al.. (2013). Adherence and Persistence in the Use of Warfarin After Hospital Discharge Among Patients With Heart Failure and Atrial Fibrillation. Journal of Cardiac Failure. 20(1). 23–30.
15.
Jones, W. Schuyler, Xiaojuan Mi, Manesh R. Patel, et al.. (2013). Combined Use of Warfarin and Oral P2Y12 Inhibitors in Patients With Atrial Fibrillation and Acute Coronary Syndrome. Clinical Cardiology. 37(3). 152–159.
16.
Piccini, Jonathan P., Xiaojuan Mi, Tracy A. DeWald, et al.. (2012). Pharmacotherapy in Medicare beneficiaries with atrial fibrillation. Heart Rhythm. 9(9). 1403–1408.
17.
Kato, Mahoto, Lynne W. Stevenson, Maryse Palardy, et al.. (2012). The Worst Symptom as Defined By Patients During Heart Failure Hospitalization: Implications for Response to Therapy. Journal of Cardiac Failure. 18(7). 524–533.
18.
Hernandez, Adrian F., Xiaojuan Mi, Bradley G. Hammill, et al.. (2012). Associations Between Aldosterone Antagonist Therapy and Risks of Mortality and Readmission Among Patients With Heart Failure and Reduced Ejection Fraction. JAMA. 308(20). 2097–2097.
19.
Mi, Xiaojuan, Kent M. Eskridge, Varghese George, & Dong Wang. (2011). Structural Equation Modeling of Gene-Environment Interactions in Coronary Heart Disease. Annals of Human Genetics. 75(2). no–no.
20.
Mi, Xiaojuan, Kent M. Eskridge, Dong Wang, et al.. (2010). Regression-Based Multi-Trait QTL Mapping Using a Structural Equation Model. Statistical Applications in Genetics and Molecular Biology. 9(1). Article38–Article38.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Sameer Bansilal Breakdown of academic impact, for papers by Ruoxiang Jiang Breakdown of academic impact, for papers by Amit Kiran Breakdown of academic impact, for papers by Charles Porter Breakdown of academic impact, for papers by Shweta R. Motiwala Breakdown of academic impact, for papers by Mary Tan Breakdown of academic impact, for papers by A. Mosterd Breakdown of academic impact, for papers by Yumin Zhao Breakdown of academic impact, for papers by Bruce M. Psaty Breakdown of academic impact, for papers by Piotr Jankowski